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Introduction: Application of noxious stimulation to one body area reduces pain sensitivity in 
a remote body area through activation of an endogenous pain-inhibitory network, a behavioral 
phenomenon referred to as conditioned pain modulation (CPM). The efficiency of CPM is 
predictive of a variety of health outcomes, while impaired CPM has been associated with vari-
ous chronic pain conditions. Current methods used to assess CPM vary widely, and interest in 
CPM method development remains strong. Here, we evaluated a novel method for assessing 
CPM in healthy controls and fibromyalgia (FM) patients using thumb pressure as both a test 
and conditioning stimulus.
Methods: Sixteen female FM patients and 14 matched healthy controls underwent CPM testing 
with thumbnail pressure as the test stimulus, and either cold water or noxious pressure as the 
conditioning stimulus. CPM magnitude was evaluated as the difference in pain rating of the test 
stimulus applied before and during the conditioning stimulus.
Results: In healthy controls, application of either pressure or cold water conditioning stimulation 
induced CPM as evidenced by a significant reduction in test stimulus pain rating during condi-
tioning (P=0.007 and P=0.021, respectively). In contrast, in FM patients, neither conditioning 
stimulus induced a significant CPM effect (P>0.274). There was a significant difference in CPM 
magnitude for FM patients compared to healthy controls with noxious pressure conditioning 
stimulation (P=0.023); however, no significant difference in CPM was found between groups 
using cold water as a conditioning stimulus (P=0.269).
Conclusion: The current study demonstrates that thumbnail pressure can be used as both a 
test and conditioning stimulus in the assessment of CPM. This study further confirms previous 
findings of attenuated CPM in FM patients compared with healthy controls.
Keywords: pressure pain, cold pressor test, diffuse noxious inhibitory controls, quantitative 
sensory testing
Introduction
In both healthy humans and animals, application of noxious stimulation activates one 
or more endogenous networks resulting in conditioned pain modulation (CPM). Many 
different methods have been used to evaluate CPM,1,2 but no standard experimental 
paradigm has emerged. Nearly all such paradigms, however, incorporate both a condi-
tioning stimulus (a noxious stimulus that evokes CPM) and a test stimulus (a noxious 
stimulus used to evaluate the analgesic response to the conditioning stimulus).3,4 The 
magnitude of CPM is typically calculated as the difference in pain ratings of the test 
stimulus at baseline and during or immediately following application of the condi-
tioning stimulus. A reduction in test stimulus rating as a result of application of the 
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conditioning stimulus implies functional or intact (inhibitory) 
CPM, and the degree of reduction expresses the magnitude or 
“efficiency” of CPM. In contrast, an increase in test stimulus 
rating during conditioning implies pain facilitation.
It has been hypothesized that healthy individuals with 
inefficient CPM are more susceptible to developing chronic 
pain disorders than are those with efficient CPM.5–7 In addi-
tion, inefficient CPM has been shown to be associated with 
increased analgesia requirements and postsurgical pain,8,9 
and it has also been consistently observed in fibromyalgia 
(FM) patients compared to healthy controls.10–16 Although the 
precise neurobiological determinants for CPM are unknown, 
it has been shown in animals to be mediated in part by supra-
spinal inhibition of second-order neurons that transmit noci-
ceptive information from primary nociceptors to the brain.17–19
Here, we performed a proof-of-concept validation study 
of a novel CPM paradigm in FM patients and healthy controls 
in which pressure applied to the thumbnail bed was used 
as both a test stimulus and a conditioning stimulus. This 
paradigm was compared to a more established method using 
pressure as a test stimulus and cold water hand immersion 
(ie, cold pressor task) as a conditioning stimulus.20–24
Methods
Subjects
Sixteen right-handed female patients (mean ± standard 
deviation [SD], age 44.9±9.0 years, range: 24–57) satisfying 
1990 American College of Rheumatology criteria for FM25 
participated. A clinical pain score rated ≥40 on a 100 mm 
visual analog scale (with 0= no pain and 100= worst possible 
pain) was required for enrollment. Fourteen age-matched 
(40.3±12.0 years, range: 20–60) female healthy control 
subjects were also recruited. All subjects provided a medical 
history and underwent physical examination to screen for 
concurrent illnesses. Exclusion criteria consisted of signifi-
cant medical and psychiatric comorbidities, including morbid 
obesity, substance abuse within 2 years (including cannabis), 
cardiovascular disease, lung disease, major depression, and 
schizophrenia, and current use of opioid analgesics. Other 
medications for depression, anxiety, and pain were permitted 
in the FM group as long as stable dosages were maintained 
during the course of the study. The protocol was approved 
by the University of Michigan Institutional Review Board, 
and all subjects gave written consent prior to participation.
CPM assessment
We adapted the CPM paradigm of Granot et al, including 
their time parameters and method of stimulus presentation, 
for pressure stimuli as we have reported previously.26,27 Sub-
jects underwent CPM testing with noxious pressure as the 
test stimulus, and either noxious pressure (n=15; eight FM 
patients and seven healthy controls) or noxious cold water 
(n=22; ten FM patients and twelve healthy controls) as the 
conditioning stimulus. Of the 30 subjects enrolled in this 
study, a subset of subjects (n=7; two FM patients and five 
healthy controls) participated in both pressure and cold water 
trials. Repeated visits were counterbalanced and separated by 
a minimum of 3 weeks to prevent potential carryover effects 
from the previous trial.
An initial psychophysical test identified the pressure 
intensity that would be used as the test stimulus and the 
conditioning pressure stimulus. Psychophysical testing 
was performed using methods previously validated by our 
group for the measurement of mechanical pain sensitiv-
ity.28–35 Instructions were scripted and subjects underwent a 
familiarization/training prior to testing. A series of discrete 
pressures was applied to the thumbnail bed with a 1 cm2 
hard rubber circular probe attached to a hydraulic piston. 
The thumbnail was chosen in part because it represents a 
“neutral site” that is not associated with FM tender points, 
and it has been shown to be highly representative of overall 
pressure sensitivity throughout the body.36 The probe was 
positioned over the center of the subject’s dominant (right) 
thumbnail by a handheld plastic housing with a pistol-like 
grip, and the hydraulic system was activated by placing 
calibrated weights on a moveable platform and adjusting 
valves to control stimulus timing. The probe was lowered to 
apply pressure consistent with the weight on the moveable 
platform. The combination of valves and calibrated weights 
produced controlled and repeatable stimulation.
Each pressure application was 5 seconds in duration and 
delivered at 20 seconds intervals, beginning with 0.25 kg/cm2 
and increasing in 0.25–0.50 kg/cm2 increments thereafter to 
either a maximum of 10 kg/cm2 or to tolerance (defined here 
as the first stimulus to elicit a rating of 80/100 or greater, 
or when subjects requested the test be stopped). Subjects 
used a 0–100 numerical rating scale (NRS) to verbally rate 
the intensity of the perceived pain sensation immediately 
following release of each pressure application. Zero was 
defined as “no pain”, and 100 was defined as “pain as bad 
as it could be”. From these ratings, regression analysis was 
used to interpolate the pressure value corresponding to a pain 
intensity rating of 60 on a 0–100 NRS (pain-60). The pain-
60 pressure served as the test stimulus during both pressure 
and cold water CPM trials and as the conditioning stimulus 
during the pressure CPM trials.
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Prior to conditioning stimulation, baseline pain elicited 
by the pain-60 test stimulus was rated three times on a 0–100 
NRS after 10, 20, and 30 seconds of continuous pressure 
(Figure 1) applied to the nondominant (left) thumbnail using 
the device described above. Five minutes after baseline test-
ing, CPM was induced by applying 60 seconds of continuous 
pain-60 pressure to the dominant thumbnail. Alternatively, 
CPM was induced by immersing the subjects’ dominant hand 
up to the wrist into a 12°C refrigerated circulating water bath 
(NESLAB Digital One RTE 7, Thermo Scientific, Newing-
ton, NH, USA) for 60 seconds. Pilot testing determined 
this temperature to be lowest tolerable by both FM patients 
and healthy controls. Subjects maintained their hand in an 
open, relaxed position for the duration. Parallel to the last 30 
seconds of the pressure or cold water conditioning stimulus, 
the same test stimulus was reapplied to the nondominant 
thumbnail and rated every 10 seconds (at 40, 50, and 60 
seconds). Subjects were also asked to rate the conditioning 
stimulus at the end of testing.
Data analysis
Group ages were compared by independent samples t-test. 
Within each group (healthy controls and FM patients), dif-
ferences in test stimulus ratings before and during pressure 
and cold water conditioning were assessed separately with 
paired samples t-tests. These analyses were conducted to 
determine whether each paradigm produced a CPM effect. To 
compare the magnitude of the CPM effect between groups, 
a difference score was calculated for each subject by sub-
tracting baseline ratings of the test stimulus from ratings of 
the test stimulus obtained during conditioning stimulation 
(Test
conditioning 
−
 
Test
baseline
). Thus negative values reflect pain 
inhibition,  whereas positive values reflect pain facilitation.3 
Differences in CPM magnitude between groups and between 
conditioning stimuli (pressure and cold water) were assessed 
by independent samples t-tests. Results are presented as 
mean NRS pain ratings ± SD. Analyses were conducted with 
SPSS 22 (IBM, Armonk, NY, USA). A P-value of <0.05 was 
considered statistically significant.
Results
There was no significant difference in age between FM 
patients and healthy controls (t=−1.21, df=28, P=0.236). 
FM patients reported an average clinical pain score of 
61.47±14.36 (range: 41–97) visual analog scale units, and 
reported using the following medications: pregabalin (n=6), 
bupropion (n=3), nonsteroidal anti-inflammatory drugs 
(n=3), amidrine (n=1), amitriptyline (n=1), escitalopram 
(n=1), lorazepam (n=1), and zolpidem (n=1).
In healthy controls, intact inhibitory CPM was identified 
by significant differences in means of test stimulus pain rat-
ings taken at baseline and during thumbnail pressure pain 
conditioning stimulation (54.62±13.01 vs 40.76±19.93, 
respectively; t=4.06, df=6, P=0.007) and during cold water 
conditioning stimulation (50.97±22.13 vs 32.50±19.04; 
t=2.69, df=11, P=0.021) (Figure 2). In contrast, FM patients 
exhibited no significant change in mean pain ratings of 
the test stimulus obtained before and during pressure 
(47.58±24.69 vs 51.88±25.14; t=−0.73, df=7, P=0.487) 
or cold water (54.90±18.80 vs 47.33±24.64; t=1.16, df=9, 
P=0.274) conditioning stimulation (Figure 2). Both pres-
sure and cold water conditioning stimuli were perceived as 
painful; healthy controls rated the cold water conditioning 
stimulus as 56.67±19.23 and the pressure conditioning stimu-
lus as 47.00±10.95, while FM patients rated the cold water 
as 80.00±18.71 and the pressure as 51.25±14.36.
10
Test stimulus
(nondominant thumbnail)
Conditioning stimulus
(dominant thumbnail)
Test stimulus
(nondominant thumbnail)
20 30 30 40 50 60(5 min rest) 00
R R R R R R
Sec
Figure 1 CPM paradigm.
Notes: Individually predetermined pain-60 test pressure was applied to the nondominant thumbnail for 30 seconds at baseline. After a 5 minute rest, the conditioning 
stimulus (either a pain-60 pressure to the dominant thumbnail or immersion of the dominant hand in a 12°C water bath) was applied for 60 seconds. For the last 30 seconds 
of the conditioning stimulus, the original test stimulus was reapplied to the nondominant thumbnail.
Abbreviations: CPM, conditioned pain modulation; min, minutes; R, time point at which subjects rated the test stimulus; Sec, seconds.
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We further compared the CPM magnitude between 
healthy controls and FM patients for each conditioning 
stimulus using independent samples t-tests. For pressure 
conditioning, there was a significant difference in the CPM 
magnitude between groups (–13.86±9.03 for healthy controls 
vs 4.29±16.55 for FM patients; t=−2.58, df=13, P=0.023). 
For cold water conditioning, the difference between groups 
was not significant (−18.47±23.79 for healthy controls vs 
−7.57±20.55 for FM patients; t=−1.14, df=20, P=0.269).
Within each group of subjects, the effect of type of condi-
tioning stimulus on CPM magnitude was not significant. For 
healthy controls, CPM magnitude was −18.47±23.79 as a result 
of cold water conditioning stimulation and was −13.86±9.03 
as a result of pressure conditioning stimulation (t=−0.488, 
df=17, P=0.632). For FM patients, the CPM magnitude was 
−7.57±20.55 as a result of cold water conditioning  stimulation 
and was 4.29±16.55 as a result of pressure conditioning stimu-
lation (t=−1.32, df=16, P=0.205).
Discussion
To the best of our knowledge, this is the first study to evalu-
ate CPM in healthy controls and FM patients using discrete 
thumbnail pressure as both a test and conditioning stimulus. 
We demonstrated that pressure pain conditioning stimulation 
applied to the thumbnail is at least as effective as cold water 
immersion of the hand for inducing CPM when pressure 
pain to the contralateral thumbnail is used as a test stimulus.
Few studies have compared different conditioning stimuli 
in CPM paradigms. Arendt-Nielsen et al used either deep 
muscle pain (hypertonic saline injection into tibialis anterior) 
or cold water immersion of the hand to evaluate magnitude 
of CPM in young, healthy subjects.21 They concluded that 
C
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Figure 2 Changes in pain ratings in HC and FM patients during a CPM paradigm.
Notes: CPM was assessed by using pressure pain applied to the nondominant left thumbnail as the test stimulus and either pressure pain to the contralateral thumbnail 
(A) or cold water immersion of the contralateral hand (B) as the conditioning stimulus. Decreases in test stimulus pain ratings during conditioning stimulation are an 
indication of intact CPM. Note that not all healthy controls exhibited CPM and not all FM patients exhibited a lack of CPM. (C) Pain ratings (mean ± SD) at baseline and 
during CPM are shown by group and stimulus. Differences in test stimulus ratings before and during CPM were assessed with paired-samples t-tests. In healthy controls, the 
mean pain rating of the test stimulus significantly decreased when either pressure pain (n=7) or cold water (n=12) was used as the conditioning stimulus. In FM patients, the 
mean pain rating did not significantly change regardless of conditioning stimulus used (pressure pain, n=8; cold water, n=10). A subset of subjects (n=7) underwent both test 
stimuli on separate visits.
Abbreviations: CPM, conditioned pain modulation; FM, fibromyalgia; HC, healthy control; SD, standard deviation.
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saline injections were effective at increasing pressure pain 
thresholds in males but not in females, while cold water 
was able to increase pressure pain thresholds in both sexes. 
Granot et al also evaluated CPM magnitude in young, healthy 
subjects and used either hot water or cold water as a condi-
tioning stimulus and heat pain as a test stimulus; they found 
that both conditioning stimuli were able to induce CPM in 
their subjects.26 Our study evaluated only females, both with 
and without FM, and each of the two conditioning stimuli 
induced CPM in healthy controls.
A number of previous studies have identified attenuated 
CPM in the majority of FM patients,10–13,15,16 and this was 
corroborated by a meta-analysis that concluded that CPM is 
impaired in many chronic pain disorders.7 Some have sug-
gested that CPM dysfunction is a pathogenic factor in the 
development of chronic pain.5–7 An alternative explanation 
for absent or reduced CPM in FM and similar chronic pain 
conditions is that CPM systems are already activated at base-
line and cannot be increased further by noxious condition-
ing stimulation.28 Accordingly, FM may not be the result of 
dysfunctional CPM, but rather the cause of an overwhelmed 
CPM system operating at maximal output. In this study, we 
demonstrated that evaluating CPM by using pressure pain 
as both a conditioning and test stimulus can identify intact 
CPM in healthy subjects, as well as attenuated CPM in FM 
patients. It is important to note, however, that not every 
healthy control subject exhibited intact CPM, and not every 
FM patient exhibited attenuated CPM (Figure 2). Findings 
of both pain inhibition and pain facilitation within groups 
of individuals are not uncommon in studies of CPM,37,38 and 
reflect significant interindividual variability in endogenous 
pain control mechanisms.39
Interestingly, although there was no statistically sig-
nificant difference in CPM magnitude between conditioning 
stimuli within the group of FM patients, CPM was numeri-
cally more efficient (ie, greater inhibition) with cold water 
conditioning. Cold water conditioning produced a net pain 
inhibitory effect (−7.57 NRS units), whereas pressure pain 
conditioning produced a net pain facilitatory effect (4.29 NRS 
units). This might be explained by the fact that FM patients 
in our study experienced the cold water as more painful 
than the pressure pain conditioning stimulus, and indeed 
several studies have suggested that more painful conditioning 
stimuli result in more robust endogenous pain inhibition.40–42 
Additional evidence, however, suggests that increasing the 
intensity or perceived painfulness of conditioning stimulation 
(as long as it is initially perceived as painful) does not affect 
CPM magnitude, which may represent a ceiling effect,26,43,44 
and these studies support our finding that the differences 
in CPM between conditioning stimuli in our study are not 
statistically significant. Nevertheless, it is worth noting that 
a group difference in CPM magnitude was only observed 
in this study with pressure pain conditioning. The reason 
for this is unknown but it may be related to small sample 
size, the potential influence of anxiety on pressure-based 
CPM testing,45 and/or the greater inhibitory effect of cold 
water conditioning in this group of FM patients relative to 
the controls.
Another intriguing aspect of this issue relates to the evolv-
ing understanding regarding mechanisms governing cold and 
cold pain sensation, such as the activation of the transient 
receptor potential cation channel, subfamily M, member 8 
(TRPM8) and transient receptor potential cation channel, sub-
family A, member 1 (TRPA1), respectively.46 These receptors, 
which play a complex role in the mediation of both cold-related 
pain and analgesia, are potential targets of pharmacological 
manipulation by various agonists and antagonists.47 Thus, the 
role played by medications used by FM patients in the cur-
rent study, including pregabalin, must be kept in mind when 
evaluating the differences between the groups. Additional 
studies with larger sample sizes and measures of psychological 
factors will be necessary to more fully characterize the effect 
of conditioning stimulus type on detecting CPM differences 
between healthy controls and FM patients.
As previously described by Yarnitsky et al, assessing 
CPM may have clinical utility in patients suffering from 
chronic pain.9 Thus, in patients suffering from painful 
diabetic neuropathy, impaired CPM was shown to cor-
relate with an improved clinical response to duloxetine, a 
serotonin–norepinephrine reuptake inhibitor (SNRI). This 
finding was interpreted as indicating that treatment with an 
SNRI could restore more efficient CPM, thus being particu-
larly useful for patients with a baseline CPM impairment. 
Further elaborating on this notion, it has subsequently been 
proposed that experimental methods can be used to establish 
a pain modulation profile, based on the measurement of 
CPM as well as temporal summation, thus establishing a 
pain inhibitory/facilitatory balance; the assumption being 
that this pain phenotype may be used to position individuals 
on a pronociceptive/antinociceptive spectrum.39 While the 
link between impaired CPM and response to SNRIs has yet 
to be shown in FM, which is also frequently treated with 
this class of medication, a similar response would appear to 
be predictable, based on the frequency of CPM impairment 
among FM patients. In view of the notorious sensitivity of 
FM patients to side effects of medications (including SNRIs) 
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and the less-than-optimal response to pharmacological treat-
ments in general,48 it would be particularly useful to develop 
practical and simple methods for performing longitudinal 
CPM assessment among FM patients. Ideally, such methods 
implemented in the clinical setting might serve to guide 
patient-tailored treatment and reduce the rates of treatment 
failure, which are so typical of the trial-and-error strategy.49,50
The pressure paradigm presented in the current study 
does not require sophisticated and cumbersome equipment 
(eg, thermodes, hot/cold water vessels) and thus provides 
an easy-to-use standardized CPM-assessment method to be 
introduced into clinical practice. Additionally, the equip-
ment utilized in the current study can easily be adapted for 
use in a magnetic resonance imaging (MRI) environment, 
thus facilitating neuroimaging research into the neurobio-
logical correlates of CPM. Indeed, using a pneumatic piston 
controlled by a computerized system, we have been able to 
perform preliminary assessments of CPM during functional 
MRI (fMRI) (unpublished data). Such methods can be used 
both for evaluating brain responses to phasic pain stimuli,28,51 
as well as identifying areas activated during CPM, and can be 
used for comparing patterns of brain activation during CPM 
among patients with chronic pain compared with healthy 
controls (see Figure S1for examples of fMRI scanning per-
formed during pressure-based CPM).
The neurobiological correlates of CPM in humans have 
begun to be explored by functional neuroimaging. A recent 
fMRI study in healthy individuals using a different CPM 
paradigm (electrical stimulation of the sural nerve as a test 
stimulus and cold water immersion of the contralateral foot 
as a conditioning stimulus) showed decreased activity during 
CPM in brain regions involved in pain processing, including 
the anterior cingulate cortex, supplementary motor area, 
primary somatosensory cortex, and insula.52 In a separate 
fMRI study, the right leg was surrounded on three sides by 
bags of ice water as a tonic conditioning stimulus while a 
fixed-temperature heat thermode (47.5°C) was applied to the 
left forearm as a phasic test stimulus.53 The authors observed 
significantly decreased activity in the insula, anterior cingulate 
cortex, thalamus, amygdala, and medulla during CPM. Sub-
sequently, individual differences in CPM have been shown to 
be related to different levels of prefrontal cortical activation 
during the early part of the CPM stimulus, possibly due to 
different levels of anxiety.38 Interestingly, while performing 
CPM during fMRI scanning, we observed increased activation 
at the red nucleus area of the midbrain among healthy controls, 
but not among FM patients (Figure S1). Further research is 
necessary in order to elucidate the role of the midbrain as well 
as other areas involved in CPM and to distinguish between 
normal and pathological patterns of activation.
Conclusion
In summary, we have shown that noxious pressure applied 
to the thumbnail bed can be used as both a conditioning and 
test stimulus to evaluate CPM in FM patients and healthy 
controls. This paradigm was as effective at inducing CPM as 
a more established method using cold water hand immersion 
as a conditioning stimulus and pressure as a test stimulus. In 
contrast to other CPM paradigms that use either sophisticated 
and/or cumbersome test stimuli or very noxious conditioning 
stimuli that individuals – particularly those suffering from 
chronic pain – may be reluctant to undergo repeatedly, this 
paradigm to evaluate CPM can be performed longitudinally 
in nearly any setting with minimal participant burden.
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Figure S1 Pressure-based CPM during functional magnetic resonance imaging.
Notes: A comparison of BOLD signal pattern during a CPM scan (moderately painful pressure test stimulus and conditioning stimulus applied concurrently to both 
thumbnails) to that obtained during a baseline scan (test stimulus alone applied to one thumbnail), revealed a significant effect of conditioning stimulation in female healthy 
controls (n=10) in the left red nucleus (x=−5, y=−14, Z=4.27, corrected, P<0.01), contralateral to the conditioning stimulus.
Abbreviations: CPM, conditioned pain modulation; min, minutes; sec, seconds.
